ADIPOQ and metabolic dysfunction-associated steatohepatitis: Thus, one study in patients with NASH shows that increases of adiponectin produced by pioglitazone are related to improvements in steatosis, inflammation and fibrosis, thereby confirming the crucial role of adiponectin in this pathology [75].